Clinical Utility of Various Formulations of Calcipotriene and Betamethasone Dipropionate for the Treatment of Plaque Psoriasis in Patients Aged 12 Years or Older
Kamila Kędra,1,2 Adam Reich1 1Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, 35-055, Poland; 2Doctoral School, University of Rzeszow, Rzeszow, PolandCorrespondence: Adam Reich, Email adamandrzejreich@gmail.comAbstract: Plaque-type...
Saved in:
Main Authors: | Kędra K, Reich A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-utility-of-various-formulations-of-calcipotriene-andbetametha-peer-reviewed-fulltext-article-DDDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment
by: Jun Li, et al.
Published: (2024-11-01) -
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional, online survey
by: José Luis López Estebaranz, et al.
Published: (2024-12-01) -
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice
by: Gabriella Fabbrocini, et al.
Published: (2022-07-01) -
Evaluation of psoriasis patients with long-term topical corticosteroids for their risk of developing adrenal insufficiency, Cushing’s syndrome and osteoporosis
by: Betul Erdem, et al.
Published: (2024-12-01) -
Characteristics of Patients with Generalized Pustular Psoriasis: A Report of the Polish Generalized Pustular Psoriasis Group
by: Marta Kołt-Kamińska, et al.
Published: (2024-11-01)